Healthcare services carries a benchmark band of 5.0x – 8.5x adjusted EBITDA at a $3–5M-EBITDA control sale — and it is the widest band of the nineteen sectors in our industry multiple table. That width is the most important fact on this page. A 3.5-turn spread means the sector label tells a buyer almost nothing; what is inside the practice decides the number.
Two things separate the top of that band from the bottom, and neither is clinical quality: whose revenue it is, and whether a buyer can lawfully own it.
Why the band is so wide
A practice at the top of the band and a practice at the bottom can look nearly identical on a P&L. What differs:
- Payer mix. A book weighted toward commercial payers with negotiated rates underwrites differently from one dependent on government reimbursement, where the rate is set by someone else and can be revised without your input. Buyers are not pricing this year’s margin; they are pricing the durability of the rate behind it.
- Referral transferability. This is the sector’s version of owner dependence, and it is harsher. If patients come because of a specific physician’s relationships, the buyer is acquiring a stream that may walk out with that physician. A practice whose referrals come from institutional sources — contracts, health system relationships, payer steerage — is a fundamentally more transferable asset.
- Provider concentration. One clinician generating 40% of collections is the same underwriting problem as one customer at 40% of revenue, plus a licensure dimension.
- Sub-sector. Behavioral health, home-based care and fertility have drawn concentrated buyer interest; a single-specialty practice in a category nobody is consolidating this year has fewer bidders, and buyer competition is a meaningful part of any multiple.
The ownership question most owners have never had to ask
In most states the corporate practice of medicine doctrine prevents an unlicensed entity from owning a medical practice or employing physicians outright. That is state law, and it varies, but it is the default constraint across much of the country.
The response the market has built is the management services organization. The professional corporation stays owned by a licensed physician and holds the clinical assets and the clinical staff; the MSO owns everything else and takes a long-term management agreement with the practice, with a management fee that draws out substantially all of the economics. When you read that a private equity firm “bought” a practice, an MSO structure is usually what happened.
For a seller, this has a consequence worth understanding before the first meeting: what you are selling may not be the practice. It is the management company and the contractual rights attached to it. The economics can be equivalent. The governance is not, and the differences live in a management services agreement most owners read once, late.
The regulatory ground is moving, and it moves multiples
This is a timing consideration rather than a permanent condition, and it cuts in one direction.
In June 2026 the American Medical Association adopted policy stating that physician practices delivering medical care should be majority owned by actively practicing licensed physicians who retain final authority over clinical decision-making and operational decisions affecting patient care, while opposing contractual mechanisms that let unlicensed entities exert direct or de facto control. AMA policy is advocacy, not law — but it is a reliable leading indicator of where state legislatures go, and several states enacted additional guardrails in 2025 addressing transaction notification, MSO control and restrictive covenants.
The valuation implication is straightforward. Every constraint on what an MSO may control narrows what a financial buyer can underwrite, and a narrower underwriting supports a lower multiple. Owners who assume today’s structures will be available indefinitely are making an assumption the legislative record does not support.
It is also a reason the third option most healthcare owners are never shown deserves a look: a structure where the clinicians already inside the practice become the buyers does not depend on how a legislature decides to treat outside control.
What the spread is worth in dollars
Two practices, both $4M of adjusted EBITDA, same sub-sector:
| Practice A | Practice B | |
|---|---|---|
| Payer concentration | No payer over 10% | One payer over 25% |
| Founder dependence | Runs without the founder | Founder drives 40% of referrals |
| Growth | Consistent | Flat |
| Adjusted band | 5.6x – 9.6x | 3.8x – 6.5x |
| Enterprise value | $22.5M – $38.2M | $15.2M – $25.9M |
Midpoint to midpoint, Practice A is worth roughly 48% more on identical earnings in an identical sector. None of that gap is clinical. All of it is structural, and most of it is addressable with two or three years of runway — which is exactly why the worst time to learn this is when an offer is already on the table.
What buyers diligence here that they do not elsewhere
- Payer contracts and rate schedules, including any that renegotiate inside the buyer’s hold period.
- Referral source analysis — concentration by referring provider, and whether relationships sit with the practice or with an individual.
- Regulatory compliance posture, including billing and coding practices. A coding pattern that inflates collections is not an add-back; it is a liability that survives the sale.
- Provider contracts and restrictive covenants, because a buyer is acquiring the clinicians’ continued presence as much as the entity.
- Structural compliance of any existing MSO arrangement against the law of every state the practice operates in.
Frequently asked questions
What multiple do healthcare practices sell for?
Our benchmark band is 5.0x to 8.5x adjusted EBITDA at $3–5M of earnings — the widest band of any sector we track. Where a practice lands depends far more on payer mix, referral transferability and provider concentration than on the specialty itself.
Why is the healthcare band wider than other industries?
Because two practices with identical earnings can carry completely different risk. One with diversified commercial payers and institutional referral sources is durable; one built on a single payer contract and one physician’s relationships may not survive the physician’s departure. The band has to be wide enough to hold both.
Can a private equity firm actually own my medical practice?
In most states, not directly. The corporate practice of medicine doctrine restricts unlicensed entities from owning practices or employing physicians, so buyers use a management services organization: the professional corporation stays physician-owned and holds the clinical side, while the MSO holds everything else under a long-term management agreement. What changes hands is usually the management company, not the practice.
Does the current wave of state regulation affect what my practice is worth?
Over time, yes. Constraints on what an MSO may control narrow what a financial buyer can underwrite, and narrower underwriting supports lower multiples. Several states added guardrails in 2025 covering transaction notification, MSO control and restrictive covenants, and the direction of travel has been consistent.
What raises a healthcare practice’s multiple the most?
Making the revenue transferable. Diversifying payers, moving referral relationships from individuals to the institution, and building clinical leadership that does not depend on the founder. Those three move a practice from the bottom of the band toward the top, and in this sector that spread is worth close to half the value of the business.
See where your practice lands
Run the valuation calculator